Skip to main content
InnoCare Pharma Limited (HKG:9969)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
13.72
-0.33 (-2.35%)
Apr 29, 2026, 4:08 PM HKT

InnoCare Pharma Revenue

InnoCare Pharma had revenue of 528.63M CNY in the quarter ending March 31, 2026, with 38.65% growth. This brings the company's revenue in the last twelve months to 2.52B, up 105.92% year-over-year. In the year 2025, InnoCare Pharma had annual revenue of 2.37B with 135.27% growth.

Revenue (ttm)
2.52B CNY
Revenue Growth
+105.92%
P/S Ratio
9.91
Revenue / Employee
2.14M CNY
Employees
1,176
Market Cap
28.40B HKD

Revenue Chart

* This company reports financials in CNY.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20252.37B1.37B135.27%
Dec 31, 20241.01B270.91M36.68%
Dec 31, 2023738.54M113.13M18.09%
Dec 31, 2022625.40M-417.63M-40.04%
Dec 31, 20211.04B1.04B76,368.70%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Genscript Biotech 7.47B
Shanghai Bao Pharmaceuticals 54.70M
Duality Biotherapeutics 2.06B
Keymed Biosciences 797.12M
Zai Lab 3.58B
Ascletis Pharma 2.26M
Shanghai Junshi Biosciences 2.78B
Shanghai Henlius Biotech 7.42B
Revenue Rankings

InnoCare Pharma News

More News